Cargando…
Multisession radiosurgery for grade 2 (WHO), high risk meningiomas. A phase II clinical trial
PURPOSE: Patients suffering from recurrent and residual grade 2 (WHO) meningiomas after subtotal excision should be considered as high-risk groups with an uncertain prognosis. Adjuvant radiotherapy seems to be the best approach to reduce disease progression. The primary aim of this phase II explorat...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8979484/ https://www.ncbi.nlm.nih.gov/pubmed/35378640 http://dx.doi.org/10.1007/s11060-022-03978-w |